Stepcare Extended Follow-up Substudy

NCT06207942 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-04-23

No results posted yet for this study

Summary

To provide detailed information on long-term outcomes in relation to potential neuroprotection and improvements in recovery for different targets of sedation, temperature, and pressure management in post out of hospital cardiac arrest survivors at 6 and 12 months. In addition, the impact of caring for a post OHCA survivor will be explored.

Conditions

Interventions

DEVICE

Feed back controlled temperature device

If core temperature exceeds 37.7 degrees celsius a feedback controlled-device will be used at set to 37.5 degrees celsius

OTHER

High MAP

A mean arterial blood pressure (MAP) of \>85mmHg will be used. Vasopressors will be titrated to this target during 36 hours

OTHER

Deep sedation

Deep sedation for at least 36 hours

OTHER

Fever control without a device

Management of fever in the intensive care unit without a device

OTHER

Low MAP

A mean arterial blood pressure (MAP) of \>65mmHG will be used. Vasopressors will be titrated to this target during 36 hours

OTHER

Minimal sedation

A strategy of minimal sedation in the intensive care unit, used only as needed to facilitate transport, imaging and invasive procedures

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • The George Institute for Global Health, Australia

    collaborator OTHER
  • Copenhagen Trial Unit, Center for Clinical Intervention Research

    collaborator OTHER
  • Helsinki University Central Hospital

    collaborator OTHER
  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2027-01-31
Completion
2027-07-31

Countries

  • Australia
  • Belgium
  • Finland
  • Germany
  • Luxembourg
  • New Zealand
  • Norway
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06207942 on ClinicalTrials.gov